Figure 6B shows that hormonal-treated PCa patients with higher expression of HGK showed shorter BCR-free survival (HR 5.63, CI 1.58–20.06, p = 0.0027) compared to those with lower expression. The gene discussed is MAP4K4; the disease is posterior cortical atrophy.